help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daelemans, C.
Right arrow Articles by Delbaere, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daelemans, C.
Right arrow Articles by Delbaere, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 12 6310-6315
Copyright © 2004 by The Endocrine Society

Prediction of Severity of Symptoms in Iatrogenic Ovarian Hyperstimulation Syndrome by Follicle-Stimulating Hormone Receptor Ser680Asn Polymorphism

Caroline Daelemans, Guillaume Smits1, Viviane de Maertelaer, Sabine Costagliola, Yvon Englert, Gilbert Vassart and Anne Delbaere1

Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire (C.D., G.S., V.d.M., S.C., G.V.) and Laboratory of Research on Human Reproduction (Y.E., A.D.), Faculté de Médecine; and Fertility Clinic (Y.E., A.D.) and Medical Genetics Department (G.S., G.V.), Hôpital Erasme, Université Libre de Bruxelles, B-1070 Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. Anne Delbaere, Clinique de Fertilité, Hôpital Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium. E-mail: adelbaer{at}ulb.ac.be.

The ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of ovarian stimulation treatments for in vitro fertilization (IVF). Recently, three different mutations of the FSH receptor (FSHr) have been identified in patients who presented recurrent spontaneous OHSS. This prompted us to study a possible association between coding polymorphisms of the FSHr and the occurrence of iatrogenic OHSS. We sequenced the region of the FSHr gene encompassing the A307T and S680N polymorphisms of exon 10 of FSHr in 37 Caucasian females who developed OHSS after an IVF cycle in our fertility clinic, 130 Caucasian female patients who were treated by IVF but never developed OHSS, and 99 Caucasian female controls. The FSHr allele frequencies in the Caucasian control population were identical to what has already been published (39% S680 61% N680). The control IVF population was enriched in the S680 allele compared with the Caucasian control population (51% S680; 49% N680; P = 0.016). The OHSS population had a even higher enrichment in the S680 allele compared with the Caucasian control population (57% S680; 43% N680; P = 0.010). These results were unexpected, because the frequency of the S680 allele was previously found to be increased among poor responders to FSH stimulation. In a second phase, we studied FSHr allele frequencies according to the severity of OHSS. Interestingly, a significant enrichment in the allele N680 was observed as the severity of OHSS increased (P = 0.034). Bearing in mind the limitations of the small number of patients studied and the possibility of sampling biases, these results suggest that the genotype in position 680 of the FSHr cannot predict which patients will develop OHSS, but could be a predictor of severity of symptoms among OHSS patients.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M. Simoni, C.B. Tempfer, B. Destenaves, and B.C.J.M. Fauser
Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
Hum. Reprod. Update, September 1, 2008; 14(5): 459 - 484.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Binder, R. Dittrich, I. Hager, A. Muller, S. Oeser, M. W Beckmann, M. Hamori, P. A Fasching, and R. Strick
Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome
Reproduction, January 1, 2008; 135(1): 107 - 116.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. L. Ryan, X. Feng, C. B. d'Alva, M. Zhang, B. J. Van Voorhis, E. M. Pinto, A. E. F. Kubias, S. R. Antonini, A. C. Latronico, and D. L. Segaloff
Evaluating the Roles of Follicle-Stimulating Hormone Receptor Polymorphisms in Gonadal Hyperstimulation Associated with Severe Juvenile Primary Hypothyroidism
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2312 - 2317.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.Q. Yang, K.Y.K. Chan, H.Y.S. Ngan, U.S. Khoo, P.M. Chiu, Q.K.Y. Chan, W.C. Xue, and A.N.Y. Cheung
Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility
Carcinogenesis, July 1, 2006; 27(7): 1502 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C.H. de Koning, T. Benjamins, P. Harms, R. Homburg, J.M. van Montfrans, J. Gromoll, M. Simoni, and C.B. Lambalk
The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles
Hum. Reprod., February 1, 2006; 21(2): 443 - 446.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. P N Themmen
An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms
Reproduction, September 1, 2005; 130(3): 263 - 274.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. Costagliola, E. Urizar, F. Mendive, and G. Vassart
Specificity and promiscuity of gonadotropin receptors
Reproduction, September 1, 2005; 130(3): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. d'Alva, P. Serafini, E. Motta, A. C. Latronico, and B. B. Mendonca
Letter re: FSH Receptor Polymorphisms and Iatrogenic Ovarian Hyperstimulation
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4978 - 4978.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Daelemans, G. Smits, V. De Maertelaer, S. Costagliola, Y. Englert, G. Vassart, and A. Delbaere
Authors' Response: FSH Receptor Polymorphism and Iatrogenic Ovarian Hyperstimulation
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4978 - 4979.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society